CDMO

CMO

Sponsor

BIOLOGICS OUTSOURCING GLOBAL

MARKET

Contract research organizations (CROs), Contract

development and manufacturing organizations (CDMOs),
and Contract manufacturing organizations (CMOs) are
playing crucial role in global biologics market. IQ4I
Research & Consultancy published a new report on
“Biologics Outsourcing Global Market”. In addition to
Market size and Competitive intelligence, IQ4I gives
comprehensive insights on biologics outsourcing market,
trends and emerging strategies

Copyright © 2018 IQ4I

 Over the last two decades, the Pharmaceutical/Biotech industry has undergone
radical changes. The unprecedented downsizing of the internal discovery of big
pharmaceuticals, patent expiration, shift towards biologics have seen a surge in
the externalization and outsourcing activities. As the industry is looking for new
sources of discovery and development with limited resources, there is a growing
preference to move towards externalization and willingness to embrace the
concept of outsourcing, IQ4I estimates that ~23.6% of the Global R&D spending
goes into biologics development.

Almost all the major Pharmaceutical/Biotech companies are considering

outsourcing as a core strategy to fill their discovery pipelines. Outsourcing
companies that have precise capabilities through greater flexibility are the
preferred ones. Now-a-days, the big pharma relies more on CROs/CDMOs/CMOs
for biologics development and manufacturing capabilities to stock up their
pipelines.

Biologics out-paced small molecules in the global pharmaceutical market, with

seven biologics appearing in the top 10 selling drugs and only three small
molecules securing space for them in the race. The biologics global market was
estimated to be $223.6 billion in 2018 with North America holding being a major
share in the market. Asia Pacific is witnessing huge growth with many
multinational companies investing in regional players for biologics outsourcing in
key countries such as China and India. The China biologics market was estimated
to be $25.50 billion in 2018 and China biologics outsourcing market is estimated
to be for $2.1 billion. This is due to increased government funding and flexible
regulatory framework, flourishing domestic biopharmaceutical and biosimilars
market, improved capacities and capabilities that make them stand out in terms
of development and production efficiencies.

The pharmaceutical outsourcing global market was estimated to be $128.0 billion

in 2018, of which CROs account for 49.0% and CMOs accounts for 51.0%. IQ4I
estimates that the biologics outsourcing global market to be $27.0 billion in 2018.
2
Page

BIOLOGICS OUTSOURCING GLOBAL MARKET –FORECAST TO 2027

 For more information, please refer the below report content

“BIOLOGICS OUTSOURCING GLOBAL MARKET” report gives comprehensive insights

on the biologics outsourcing global market. The report covers all segments, global
trends and emerging strategies of the outsourcing market related to drug discovery,
preclinical development, clinical phases and commercial manufacturing of biologics.
Major Biologics outsourcing market players included in the report are Samsung
Biologics, Boehringer Ingelheim, Lonza, Genscript, Charles River Laboratories (CRL),
Wuxi AppTec, CMC biologics, Patheon (Thermo Fisher Scientific), Catalent, Labcorp
(Covance), and Fujifilm Diosynth biotechnologies.

This report caters the need of CROs/CDMOs/CMOs, Pharmaceutical/Biotech companies,

Academic institutes, Individual researchers, Investors, Service providers and other
associated stake holders to identify and analyze the potential of the biologics
outsourcing global market. The report also provide insights number of deals between
CRO’s and Pharmaceutical/biotech firms, employee strength of companies, revenue of
major players and therapeutic area gap analysis which are likely to have an impact on
the biologics outsourcing global market in the foreseeable future.

This report covers in-depth analysis of major players by therapeutic area of focus,
capabilities, geographic presence, financials, collaborations, acquisitions.

Some of the key sections covered in the report are given below:

Biologics Outsourcing Global Market

The biologics outsourcing global market is estimated region wise with various drug
discovery, development and manufacturing segments and their market shares. This
section also included the market sizing of antibodies, recombinant proteins, vaccines,
and others which included gene therapy, cell therapy. The emerging trends and
strategies adopted by global biopharmaceutical companies and their impact on
outsourcing market were discussed along with A list of approved Biologics (2012-2018).

 In depth assessment of all segments and sub segments of Biologics Outsourcing

global market
 Regional analysis of biologics outsourcing global market
 Market sizing based on type of Biologics, Therapeutic areas and End-Users
3
Page

 Emerging trends and strategies

BIOLOGICS OUTSOURCING GLOBAL MARKET –FORECAST TO 2027

  A list of approved biologics (2012-2018) and major biosimilars in pipeline.
 Market share analysis of major players in biologics outsourcing global market.
 Biologics services cost analysis for various modalities.
 Service provider matrix based on service offerings, revenues and employee size

Contract Biomanufacturing

Contract manufacturing market was estimated region wise with segmental revenues for
various end user groups such as diagnostics, research reagents and therapeutics. Total
available manufacturing capacity was estimated with distinction between GMP vs. non-
GMP, in-house vs. CMOs and clinical vs. commercial contract manufacturing. Key
developments such as collaborations, capacity expansions and acquisitions were
reported and analyzed.

 In depth assessment of all segments and sub-segments of contract bio-

manufacturing global market
 Regional analysis of contract bio-manufacturing global market
 Market dynamics for contract manufacturing
 Market sizing based on end users
 Emerging trends and strategies
 Market share analysis of major players in contract manufacturing global
market.
 Competitive landscape with regard to capacities for major CMOs
 CMO service matrix based on type of cell culture techniques, revenues and
employee size

Cell line development Services

The cell line development services global market was estimated region wise, by type of
cell lines expression systems, by cell types and by application. This report also contains
cost analysis for various cell line development services. Key developments such as
collaborations, acquisitions, new launches, partnerships and expansions were reported
and analyzed.

 In depth assessment of all segments and sub segments of cell line development
services global market
 Regional analysis of cell line development services global market
4
Page

 Market dynamics for cell line development services global market

BIOLOGICS OUTSOURCING GLOBAL MARKET –FORECAST TO 2027

  Cost analysis of different cell line development services and cell based assays
 Cell line type used in approved biologics (2012-2018) and analysis based on type
of modality
 Comparison matrix of various key players with cell line development capabilities

Animal Model Services

The animal model Services global market was estimated region wise, type of animal
species and therapeutic area. This report also contains ethics and regulations, animal
model alternatives and applications. Assessment of most common animal models across
different therapeutic areas was included. Key developments such as collaborations,
acquisitions, new launches, partnerships and expansions were reported and analyzed

 In depth assessment of all segments and sub segments of Animal model

outsourcing global market
 Regional analysis of Animal model services global market
 Market dynamics for animal model service global market
 Comparison matrix for species and applications
 Cost analysis of different animal model services
 Comparison matrix of animal model service providers and models in respective
therapeutic areas, revenues and employee size
5
Page

BIOLOGICS OUTSOURCING GLOBAL MARKET –FORECAST TO 2027

 ABOUT IQ4I RESEARCH & CONSULTANCY

IQ4I (Intelligence Quotient for Innovation) Research and Consultancy Pvt. Ltd. is a global
strategy, consulting and a market research firm. Our clients include leading businesses,
investment banks, researchers and government agencies.

We are a team of highly qualified consultants and market researchers, committed to

help clients make strategic decisions by providing relevant and firmly reliable
Intelligence support. We enable our clients to identify the market opportunities with
best-in-class market intelligence reports.

With world-class research capabilities, we deliver high level strategically analyzed

consulting and custom research assignments to our clients at a reasonable cost and time
frame. With fact-based insights and accurate market forecasts, we enable our clients to
understand and respond to the market dynamics with an edge over their competitors.

CONTACT

To find out more information on the “Drug Discovery Outsourcing Global Market”
please contact:

Satish Birudukota
Head-Market Research
Phone: + 91 81470 30229
Email: satish.birudukota@iq4i.com

OFFICE

IQ4I RESEARCH & CONSULTANCY PVT. LTD.

No- 41/P4, 1st Floor, Peenya I stage,
3rd Main, KIADB, Peenya-560058
6
Page

BIOLOGICS OUTSOURCING GLOBAL MARKET –FORECAST TO 2027